-
Medicine Nov 2023Actinobacillus ureae (A. ureae) is an unusual commensal of human respiratory flora, rarely causing human infection. The predisposing factors, identification, clinical... (Review)
Review
RATIONALE
Actinobacillus ureae (A. ureae) is an unusual commensal of human respiratory flora, rarely causing human infection. The predisposing factors, identification, clinical features, and antibiotic therapy of A. ureae are seldomly reported. Herein, we present a case of 64-year-old man affected by A. ureae pneumonia after intracranial surgery.
PATIENT CONCERNS AND DIAGNOSES
A 64-year-old male was admitted with vomiting, drowsiness, and a severe disturbance of consciousness and was later diagnosed with cerebral hemorrhage by computed tomography images. After a craniocerebral surgery, the patient suffered from intractable pneumonia, experiencing treatment failure with multiple anti-bacterial agents. Sputum culture yield pure colonies of A. ureae, confirmed by matrix-assisted laser desorption/ionization time of flight and 16S rRNA gene sequencing.
INTERVENTIONS
Minocycline (100 mg p.o. per 12 hours) with a course of 15 days was administrated for this patient.
OUTCOMES
The respiratory symptoms, presenting as intermittent coughing with purulent and yellowish sputum, were gone. A 3-month follow-up examination showed a complete resolution of radiological findings.
LESSONS
Clinically, the actual incidence of A. ureae pneumonia may be higher than that we generally recognized, and clinicians should consider A. ureae as a possible etiologic agent in patients with predispositions. Currently, A. ureae may be susceptible to penicillin, ampicillin, and third-generation cephalosporins. Other antibacterial agents, such as tetracycline, amoxicillin/clavulanic acid, and aminoglycosides also respond well and can be a choice in the treatment of A. ureae infections.
Topics: Male; Humans; Middle Aged; RNA, Ribosomal, 16S; Actinobacillus; Actinobacillus Infections; Anti-Bacterial Agents; Pneumonia
PubMed: 37986302
DOI: 10.1097/MD.0000000000036087 -
International Journal of Systematic and... Oct 2019Ten strains of an -like organism were isolated from alpaca () in the UK over a period of 5 years, with no known epidemiological linkages. The isolates are distinct,...
Ten strains of an -like organism were isolated from alpaca () in the UK over a period of 5 years, with no known epidemiological linkages. The isolates are distinct, based on both phenotype and genotype, from any previously described species. Molecular analysis, based on 16S rRNA, and gene sequences, placed the isolates as a novel, early branching, lineage within the currently recognised . In agreement with the results of the single-gene analysis, average nucleotide identity values, based on whole genome sequences, showed very similar identities to a number of members of the notably , and . At least two phenotypic characteristics differentiate the alpaca isolates from other species, and from taxa likely falling within this group but awaiting formal species description, with and subsp. being the most closely related phenotypically. The alpaca isolates can be differentiated from by production of β-galactosidase (ONPG) and acid from raffinose, and from subsp. by production of acid from d-sorbitol and failure to produce acid from d-xylose. Isolates were obtained from multiple sites in alpaca including respiratory tract, alimentary tract and internal organs although further evidence is required to understand any pathogenic significance. Based on the results of characterization described here, it is proposed that the isolates constitute a novel species, sp. nov. The type strain is W1618 (LMG30745 NCTC14090) isolated in the UK in 2012 from oesophageal ulceration in an alpaca ().
Topics: Actinobacillus; Animals; Bacterial Typing Techniques; Base Composition; Camelids, New World; DNA, Bacterial; Female; Genes, Bacterial; Male; Phylogeny; RNA, Ribosomal, 16S; Sequence Analysis, DNA; United Kingdom
PubMed: 31395108
DOI: 10.1099/ijsem.0.003607